% alzhub.org library filter
% Source: https://alzhub.org/research?author=Salloway+S&atag=efficacy
% 15 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{black2003-12970516,
  author  = {Black, S. and Román, G. C. and Geldmacher, D. S. and Salloway, S. and Hecker, J. and Burns, A. and Perdomo, C. and Kumar, D. and others},
  title   = {{Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial}},
  journal = {Stroke},
  year    = {2003},
  doi     = {10.1161/01.str.0000091396.95360.e1},
  pmid    = {12970516},
  url     = {https://doi.org/10.1161/01.str.0000091396.95360.e1}
}

@article{sims2023-9857475c,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and Wang, H. and Monkul Nery, E. S. and Collins, E. C. and Solomon, P. and Salloway, S. and Apostolova, L. G. and Hansson, O. and Ritchie, C. and Brooks, D. A. and Mintun, M. and Skovronsky, D. M. and {TRAILBLAZER-ALZ 2 Investigators}},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{salloway2009-19923550,
  author  = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181c67808},
  pmid    = {19923550},
  url     = {https://doi.org/10.1212/wnl.0b013e3181c67808}
}

@article{coric2012-22892585,
  author  = {Coric, V. and van Dyck, C. H. and Salloway, S. and Andreasen, N. and Brody, M. and Richter, R. W. and Soininen, H. and Thein, S. and others},
  title   = {{Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.2194},
  pmid    = {22892585},
  url     = {https://doi.org/10.1001/archneurol.2012.2194}
}

@article{salloway2004-15326237,
  author  = {Salloway, S. and Ferris, S. and Kluger, A. and Goldman, R. and Griesing, T. and Kumar, D. and Richardson, S. and {Donepezil 401 Study Group}},
  title   = {{Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000134664.80320.92},
  pmid    = {15326237},
  url     = {https://doi.org/10.1212/01.wnl.0000134664.80320.92}
}

@article{coric2015-26414022,
  author  = {Coric, V. and Salloway, S. and van Dyck, C. H. and Dubois, B. and Andreasen, N. and Brody, M. and Curtis, C. and Soininen, H. and others},
  title   = {{Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.0607},
  pmid    = {26414022},
  url     = {https://doi.org/10.1001/jamaneurol.2015.0607}
}

@article{dichgans2008-18296124,
  author  = {Dichgans, M. and Markus, H. S. and Salloway, S. and Verkkoniemi, A. and Moline, M. and Wang, Q. and Posner, H. and Chabriat, H. S.},
  title   = {{Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70046-2},
  pmid    = {18296124},
  url     = {https://doi.org/10.1016/s1474-4422(08)70046-2}
}

@article{salloway2011-21917766,
  author  = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others},
  title   = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e3182309fa5},
  pmid    = {21917766},
  url     = {https://doi.org/10.1212/wnl.0b013e3182309fa5}
}

@article{auchus2007-17664404,
  author  = {Auchus, A. P. and Brashear, H. R. and Salloway, S. and Korczyn, A. D. and De Deyn, P. P. and Gassmann-Mayer, C. and {GAL-INT-26 Study Group}},
  title   = {{Galantamine treatment of vascular dementia: a randomized trial}},
  journal = {Neurology},
  year    = {2007},
  doi     = {10.1212/01.wnl.0000266625.31615.f6},
  pmid    = {17664404},
  url     = {https://doi.org/10.1212/01.wnl.0000266625.31615.f6}
}

@article{liu2018-29429971,
  author  = {Liu, E. and Wang, D. and Sperling, R. and Salloway, S. and Fox, N. C. and Blennow, K. and Scheltens, P. and Schmidt, M. E. and others},
  title   = {{Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005060},
  pmid    = {29429971},
  url     = {https://doi.org/10.1212/wnl.0000000000005060}
}

@article{doody2009-19176895,
  author  = {Doody, R. S. and Ferris, S. H. and Salloway, S. and Sun, Y. and Goldman, R. and Watkins, W. E. and Xu, Y. and Murthy, A. K.},
  title   = {{Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/01.wnl.0000344650.95823.03},
  pmid    = {19176895},
  url     = {https://doi.org/10.1212/01.wnl.0000344650.95823.03}
}

@article{roman2010-20395618,
  author  = {Román, G. C. and Salloway, S. and Black, S. E. and Royall, D. R. and Decarli, C. and Weiner, M. W. and Moline, M. and Kumar, D. and others},
  title   = {{Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size}},
  journal = {Stroke},
  year    = {2010},
  doi     = {10.1161/strokeaha.109.570077},
  pmid    = {20395618},
  url     = {https://doi.org/10.1161/strokeaha.109.570077}
}